SELLAS Life Sciences Group, Inc. SLS Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SELLAS Life Sciences Group, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SELLAS Life Sciences Group, Inc.'s net change in cash?
- SELLAS Life Sciences Group, Inc. (SLS) reported net change in cash of $35.3M in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s net change in cash changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s net change in cash increased by 143.3% year-over-year, from $14.51M to $35.3M.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s net change in cash?
- Over 2 years (2022 to 2025), SELLAS Life Sciences Group, Inc.'s net change in cash has grown at a 279.8% compound annual growth rate (CAGR), from -$4.23M to $61.01M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.